Evrofarma SA (EVROF.AT)
EUR 1.63
(0.93%)
EUR 1.63
(0.93%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 19.49 Million EUR | -7.9% |
| 2022 | 21.16 Million EUR | -0.55% |
| 2021 | 21.28 Million EUR | 1.36% |
| 2020 | 20.99 Million EUR | 13.89% |
| 2019 | 18.43 Million EUR | -0.03% |
| 2018 | 18.44 Million EUR | -10.46% |
| 2017 | 20.59 Million EUR | 2.23% |
| 2016 | 20.14 Million EUR | -5.41% |
| 2015 | 21.29 Million EUR | -4.64% |
| 2014 | 22.33 Million EUR | -4.1% |
| 2013 | 23.28 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 16.75 Million EUR | 0.0% |
| 2023 Q2 | 22.95 Million EUR | 0.0% |
| 2023 Q1 | 22.95 Million EUR | 7.56% |
| 2023 FY | 19.49 Million EUR | -7.9% |
| 2023 Q4 | 19.49 Million EUR | 0.0% |
| 2023 Q3 | 19.49 Million EUR | -15.09% |
| 2022 Q1 | 23.81 Million EUR | 11.89% |
| 2022 Q3 | 21.34 Million EUR | -10.37% |
| 2022 Q4 | 21.34 Million EUR | 0.0% |
| 2022 FY | 21.16 Million EUR | -0.55% |
| 2022 Q2 | 23.81 Million EUR | 0.0% |
| 2021 Q3 | 21.28 Million EUR | -4.31% |
| 2021 Q1 | 22.42 Million EUR | 6.81% |
| 2021 FY | 21.28 Million EUR | 1.36% |
| 2021 Q2 | 22.24 Million EUR | -0.83% |
| 2021 Q4 | 21.28 Million EUR | 0.0% |
| 2020 Q3 | 21.19 Million EUR | 14.15% |
| 2020 Q2 | 18.56 Million EUR | -0.58% |
| 2020 Q1 | 18.67 Million EUR | 1.29% |
| 2020 Q4 | 20.99 Million EUR | -0.92% |
| 2020 FY | 20.99 Million EUR | 13.89% |
| 2019 Q1 | 17.72 Million EUR | -3.94% |
| 2019 FY | 18.43 Million EUR | -0.03% |
| 2019 Q2 | 17.73 Million EUR | 0.03% |
| 2019 Q4 | 18.43 Million EUR | -0.56% |
| 2019 Q3 | 18.53 Million EUR | 4.55% |
| 2018 FY | 18.44 Million EUR | -10.46% |
| 2018 Q4 | 18.45 Million EUR | 0.0% |
| 2018 Q2 | 19.36 Million EUR | 0.0% |
| 2018 Q1 | 19.36 Million EUR | -6.24% |
| 2018 Q3 | 18.45 Million EUR | -4.7% |
| 2017 Q4 | 20.65 Million EUR | 0.0% |
| 2017 Q1 | 20.1 Million EUR | -4.87% |
| 2017 Q2 | 20.1 Million EUR | 0.0% |
| 2017 FY | 20.59 Million EUR | 2.23% |
| 2017 Q3 | 20.65 Million EUR | 2.71% |
| 2016 Q2 | 21.99 Million EUR | 0.0% |
| 2016 Q1 | 21.99 Million EUR | -1.75% |
| 2016 FY | 20.14 Million EUR | -5.41% |
| 2016 Q4 | 21.13 Million EUR | 0.0% |
| 2016 Q3 | 21.13 Million EUR | -3.9% |
| 2015 Q2 | 22.26 Million EUR | -1.58% |
| 2015 FY | 21.29 Million EUR | -4.64% |
| 2015 Q1 | 22.61 Million EUR | -3.6% |
| 2015 Q3 | 21.95 Million EUR | -1.37% |
| 2015 Q4 | 22.38 Million EUR | 1.96% |
| 2014 Q1 | 22.77 Million EUR | -2.2% |
| 2014 Q3 | 23.03 Million EUR | 0.36% |
| 2014 Q4 | 23.46 Million EUR | 1.86% |
| 2014 FY | 22.33 Million EUR | -4.1% |
| 2014 Q2 | 22.95 Million EUR | 0.76% |
| 2013 Q2 | 22.53 Million EUR | -0.41% |
| 2013 Q4 | 23.28 Million EUR | 2.31% |
| 2013 FY | 23.28 Million EUR | 0.0% |
| 2013 Q1 | 22.62 Million EUR | 0.0% |
| 2013 Q3 | 22.76 Million EUR | 1.01% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Flour Mills Kepenos S.A. | 24.3 Million EUR | 19.805% |
| Kri-Kri Milk Industry S.A. | 12.52 Million EUR | -55.646% |
| Loulis Food Ingredients S.A. | 64.81 Million EUR | 69.929% |